Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-024245
Filing Date
2019-04-10
Accepted
2019-04-10 16:33:30
Documents
1
Period of Report
2019-04-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3371
  Complete submission text file 0001209191-19-024245.txt   4793
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SUNRUN INC. 595 MARKET STREET, 29TH FLOOR SAN FRANCISCO CA 94105
Business Address
Kim Mina (Reporting) CIK: 0001668163 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36548 | Film No.: 19741985